[1]
Hayat, I. et al. 2025. Glycemic Outcomes of Oral Hypoglycemics Versus GLP-1 Receptor Agonists in Type 2 Diabetes: A Comparative Clinical Study: Oral Hypoglycemics Versus GLP-1 Agonists in Type 2 Diabetes Glycemic Control. DEVELOPMENTAL MEDICO-LIFE-SCIENCES. 2, 10 (Oct. 2025), 23–28. DOI:https://doi.org/10.69750/dmls.02.010.0168.